LAA (Left Atrial Appendage) closure

Find all the latest content on left atrial appendage (LAA) published on this website.

Today, with an aging population, atrial fibrillation is more common and carries with it an increased risk of embolic cerebrovascular accidents. Anticoagulation strategies alone are not sufficient, and as a large proportion of the thrombus involved in these cerebrovascular accidents are seen to arise in the left atrial appendage (LAA), its closure, either surgically or by percutaneous methods, could reduce risk. Learn more about imaging, tools, devices and techniques as well as adjunctive pharmacotherapy, vascular access and bleeding here…

Filtered By
LAA closure

103 results

A novel approach to left atrial appendage occlusion (when Watchman/Amulet won’t fit!)

06 Apr 2022

See the case of a 76-year-old female patient with mitral valve repair 10 years prior found to have incomplete surgically ligated left atrial appendage, who was referred for closure.

Daniel Rothschild

Author

Daniel Rothschild
Steve Peterson

Author

Steve Peterson
Daniel S. Stewart

Author

Daniel S. Stewart
A novel approach to left atrial appendage occlusion (when Watchman/Amulet won’t fit!)

Residual Leaks Post Left Atrial Appendage Occlusion

03 Apr 2022

Michele Pighi provides his take on the National Cardiovascular LAAO Registry that analyzed data from 51,333 patients who underwent LAAO procedures with the WATCHMAN device between 2016-2019, as part of the College's NCDR registries.

M. Pighi

Author

Michele Pighi
Residual Leaks Post Left Atrial Appendage Occlusion

4-year outcomes after left atrial appendage closure versus Nonwarfarin oral anticoagulation for atrial fibrillation

24 Jan 2022

Left atrial appendage closure (LAAC) is a promising interventional treatment option for preventing cardioembolic events in non-valvular atrial fibrillation (AF) patients who can not tolerate long-term oral anticoagulation.

Reviewer

Ali Nazmi Calik
4-year outcomes after left atrial appendage closure versus Nonwarfarin oral anticoagulation for atrial fibrillation

SWISS-APERO: a randomized trial of the amulet versus watchman FLX devices for left atrial appendage closure

04 Nov 2021

The SWISS-APERO is a prospective, investigator-initiated, randomized, multi-center, and clinical trial designed to compare the Amulet and Watchman (2.5 and FLX) devices in a head-to-head fashion.

Francesco Costa

Author

Francesco Costa
SWISS-APERO: a randomized trial of the amulet versus watchman FLX devices for left atrial appendage closure

Amulet IDE: Amplatzer Amulet Left Atrial Appendage Occluder RCT - 12-Month Closure Follow-up

04 Nov 2021

Ali Nazmi Calik reviews Amulet IDE, a prospective, randomized, multi-center and active-control trial designed to compare the Amulet and Watchman 2.5 devices in a head-to-head fashion, and presented by Dhanunjaya Lakkireddy during TCT 2021.

Author

Ali Nazmi Calik
AMULET IDE: One-Year Device Closure and Device-Related Thrombus Outcomes From a Randomized Trial of Amulet versus Watchman for Left Atrial Appendage Occlusion

PCRonline @ TCT 2021 - Get the international perspective!

03 Nov 2021

Thanks to the contribution of a team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science released at TCT 2021 - check out the list here!

PCRonline @ TCT 2021

Amulet IDE: Amplatzer Amulet left atrial appendage occluder randomised controlled trial

31 Aug 2021

Luigi Biasco reports the best of Dj Lakkireddy (Overland Park, USA)'s presentation of the AMULET IDE trial at the Monday, August 30 Hot Line session of the ESC Congress 2021.

Luigi Biasco

Author

Luigi Biasco
ESC Congress 2021 - Amulet IDE: Amplatzer Amulet left atrial appendage occluder randomised controlled trial

PCRonline @ ESC Congress 2021: the interventional cardiology perspective!

21 Jul 2021

Make sure you stay up to date with what's new and hot in interventional cardiology at this year's #ESCCongress!

PCRonline @ ESC Congress 2021

EuroPCR 2021 Hotlines / Late-Breaking Trials: Alster-FLX, ANGIE, COLOR, CREDENCE BRS, and P3

27 May 2021 – From EuroPCR 2021

Find out more about various studies & registries:

  • Left atrial appendage occlusion with the WATCHMAN FLX: The Alster-FLX Registry
  • Anatomical snuffbox for coronary angiography and interventions
  • Randomized comparison between Radial and Femoral Large-bore access Complex PCI
  • Experience with BRS for treatment of de novo native peripheral artery lesions
  • Clinical validation of...
EuroPCR 2021 Hotlines / Late-Breaking Trials: Alster-FLX, ANGIE, COLOR, CREDENCE BRS, and P3

Left atrial appendage closure (LAAc) for stroke prevention - Session with LIVE demonstration

20 May 2021 – From EuroPCR 2021

Watch this session if you want to understand how to select the most suitable patients for LAA closure, to develop an approach to appropriate device selection and procedural planning, to share step-by-step implementation of procedural plans and to explore optimal post procedure follow-up and care.

This session...

Left atrial appendage closure (LAAc) for stroke prevention